Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $588,437 | 402 | 65.7% |
| Travel and Lodging | $152,647 | 575 | 17.0% |
| Consulting Fee | $85,443 | 71 | 9.5% |
| Food and Beverage | $48,536 | 1,061 | 5.4% |
| Education | $12,409 | 10 | 1.4% |
| Honoraria | $7,900 | 8 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $183,256 | 267 | $0 (2024) |
| ABBVIE INC. | $150,653 | 357 | $0 (2024) |
| Janssen Biotech, Inc. | $110,866 | 200 | $0 (2024) |
| Amgen Inc. | $109,586 | 239 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $73,578 | 165 | $0 (2024) |
| Lilly USA, LLC | $48,817 | 163 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $41,560 | 69 | $0 (2024) |
| UCB, Inc. | $34,342 | 90 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $32,188 | 89 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $29,261 | 97 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $381,849 | 726 | GENZYME CORPORATION ($109,132) |
| 2023 | $232,156 | 561 | Amgen Inc. ($62,571) |
| 2022 | $164,923 | 499 | ABBVIE INC. ($39,032) |
| 2021 | $116,443 | 341 | GENZYME CORPORATION ($23,658) |
All Payment Transactions
2,127 individual payment records from CMS Open Payments — Page 1 of 86
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $106.06 | General |
| Category: Dermatology | ||||||
| 12/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $30.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $10.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $3.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,749.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $783.52 | General |
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $577.87 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $463.50 | General |
| 12/18/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $206.21 | General |
| 12/18/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $134.44 | General |
| 12/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $120.68 | General |
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $171.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $127.09 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $85.00 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.84 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Immunology | ||||||
| 12/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $101.10 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,339.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $469.46 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,233 | 3,682 | $741,242 | $103,459 |
| 2022 | 13 | 1,098 | 2,775 | $440,869 | $84,392 |
| 2020 | 6 | 143 | 387 | $55,528 | $6,130 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 430 | $159,960 | $32,138 | 20.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 209 | 328 | $137,432 | $22,389 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 198 | $52,074 | $10,535 | 20.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 211 | 358 | $108,700 | $9,242 | 8.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 178 | 2,014 | $169,176 | $8,969 | 5.3% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 12 | 29 | $20,396 | $5,429 | 26.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 85 | 96 | $36,288 | $4,491 | 12.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $21,804 | $4,067 | 18.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 47 | $6,934 | $1,575 | 22.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $9,047 | $1,462 | 16.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $7,704 | $1,431 | 18.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 30 | $6,150 | $1,032 | 16.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 24 | $4,843 | $660.50 | 13.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 45 | $734.85 | $37.91 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 348 | $100,421 | $29,217 | 29.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 184 | 269 | $89,082 | $19,909 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 139 | $27,368 | $8,151 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 199 | 279 | $75,479 | $7,607 | 10.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 168 | 1,437 | $81,300 | $6,662 | 8.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 72 | 83 | $23,462 | $4,018 | 17.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $11,761 | $3,173 | 27.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 17 | $11,830 | $1,729 | 14.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 33 | 38 | $5,580 | $1,313 | 23.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $4,061 | $875.93 | 21.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 13 | 26 | $3,893 | $852.97 | 21.9% |
About Cynthia Trickett, PA-C
Cynthia Trickett, PA-C is a Physician Assistant healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538130216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cynthia Trickett, PA-C has received a total of $895,371 in payments from pharmaceutical and medical device companies, with $381,849 received in 2024. These payments were reported across 2,127 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($588,437).
As a Medicare-enrolled provider, Trickett has provided services to 2,474 Medicare beneficiaries, totaling 6,844 services with total Medicare billing of $193,980. Data is available for 3 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Dallas, TX
- Active Since 01/30/2006
- Last Updated 06/19/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1538130216
Products in Payments
- DUPIXENT (Biological) $247,639
- TREMFYA (Drug) $129,543
- Otezla (Drug) $106,761
- RINVOQ (Biological) $85,137
- SKYRIZI (Biological) $56,299
- TALTZ (Drug) $33,688
- Bimzelx (Biological) $32,343
- Zoryve (Drug) $30,378
- Sotyktu (Drug) $28,343
- OPZELURA (Drug) $22,373
- ILUMYA (Biological) $19,408
- Ilumya (Biological) $9,023
- HUMIRA (Biological) $8,665
- TAPINAROF (Drug) $5,467
- VTAMA (Drug) $4,906
- EUCRISA (Drug) $4,376
- ADBRY (Biological) $3,856
- DUOBRII (Drug) $2,687
- CIBINQO (Drug) $2,352
- COSENTYX (Drug) $1,764
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Dallas
Sofia Anchondo, Pa-C, PA-C
Physician Assistant — Payments: $62,309
Mr. Shawn Sommerlad, Pa-C, PA-C
Physician Assistant — Payments: $50,862
Tori Walker, Pa-C, PA-C
Physician Assistant — Payments: $38,667
Mrs. Katherine Turner, P.a.c., M.p.a.s, P.A.C., M.P.A.S
Physician Assistant — Payments: $26,889
Ms. Suzanne Racz, Pa-C, PA-C
Physician Assistant — Payments: $19,676
Katherine Sellers, Pa-C, PA-C
Physician Assistant — Payments: $17,942